Inspira Technologies Oxy BHN Ltd

Inspira Technologies Oxy B.H.N. Ltd. is engaged in research, development, manufacture, and marketing of proprietary respiratory support technology. The firm seeks to provide alternative to invasive mechanical ventilation. The company was founded by Dagi Ben Noon, Joe Hayon, and Dr. Udi Nussinovitch in July 2017 and is headquartered in Raanana, Israel.

Earnings data Q3 2021

Earnings data Q4 2021

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The company was founded by Dagi Shahar Ben Noon, Joe Hayon, and Udi Nussinovitch in July 2017 and is headquartered in Raanana, Israel.

RA'ANANA, Israel, Oct. 26, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that it has signed an exclusive distribution agreement with Anita Técnica S.L.

Inspira Technologies Enters Europe: Signs a Strategic Agreement With Waas Group for the Deployment of 1,040 ART Systems in Spain and Portugal

RA'ANANA, Israel, Oct. 13, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (NASDAQ: IINNW) (the "Company"), a specialty medical device company engaged in the research, development, manufacturing, and marketing of proprietary respiratory support technologies, today announced that the company will present in-person its ART device at the HLTH conference in Boston on October 17-20.

Inspira Technologies to Present In-Person at the HLTH Conference in Boston Sponsored by Industry Leaders such as: Philips Ventures, Microsoft, Google

RA'ANANA, Israel, Sept. 30, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

Inspira Technologies to Host COVID-19 Virtual Conference on October 6

RA'ANANA, Israel, Sept. 22, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

Inspira Technologies' "Artificial Lung" to Acquire a Digital Edge: The Company Contracted GlobalLogic, a Hitachi Group Company, for advanced digital product engineering services

RA'ANANA, Israel, Sept. 15, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

Inspira Technologies Files a Patent Application for a Supportive Device to be Utilized with the ART Device

RA'ANANA, Israel, Sept. 9, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

Inspira Technologies to Participate in Upcoming Conferences in September

RA'ANANA, Israel, Aug. 18, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira Technologies" or the "Company"), a specialty medical device company engaged in the research, development, manufacturing, and marketing of proprietary respiratory support technologies, announced today that it has successfully completed a pump bench study as the company progresses closer towards the manufacturing phase.

Inspira Technologies Reached Important Milestone as It Completed a Pump Bench Study

RA'ANANA, Israel, Aug. 13, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a specialty medical device company engaged in the research, development, manufacturing and marketing of proprietary respiratory support technologies, announced today its financial results as of and for the six months ended June 30, 2021.

Inspira Technologies Announces First Half 2021 Financial Results and Provides Business Update

RA'ANANA, Israel, Aug. 10, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company"), a specialty medical device company engaged in the research, development, manufacturing, and marketing of proprietary respiratory support technologies, today announced the appointment of Lior Amit, CPA, to the Company's board of directors.

Inspira Technologies Expands Board of Directors to Accelerate Company's Go-to-Market Efforts

RA'ANANA, Israel, July 26, 2021 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW), today announced the expansion of its North American presence with the appointment of Dr. Dekel Stavi, MD, Senior Intensive Care Clinician, for the company's Medical Advisory Board.

Inspira Expands Medical Advisory Board as Part of Future Expansion into North American Market

NEW YORK, NY / ACCESSWIRE / July 19, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $16.0 Million Initial Public Offering of Common Units for Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN, IINNW) About Inspira Technologies OXY B.H.N.

Aegis Capital Corp. acted as Sole Bookrunner on a $16.0 Million Initial Public Offering of Common Units for Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW)

RA'ANANA, Israel, July 19, 2021 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW), a breakthrough respiratory medical technology leader, announced today the completion of a development relating to the potential prevention of blood clotting when used in conjunction with its Augmented Respiration Technology (ART) system.

Inspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent Blood Clotting in Inspira's ART System

RA'ANANA, Israel, July 16, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd (the "Company"), a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology, today announced the closing of its initial public offering of 2,909,091 units at a public offering price of $5.51 per unit, each consisting of one ordinary share and one warrant to purchase one ordinary share, with an initial exercise price of $5.50 per share.

Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering

RA'ANANA, Israel  , July 13, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd (the "Company"), a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology, today announced the pricing of its initial public offering of 2,909,091 common units at a combined public offering price of $5.51, each consisting of one ordinary share and one warrant to purchase one ordinary share, with an initial exercise price of $5.50 per share.

News for Inspira Technologies Oxy BHN Ltd Stock (IINN)